Your Passport to the Newsiverse
In the crosshairs of the latest controversy on whether a drug is spurious or “not of standard quality” is the Indian patient. The pharma industry suffered a body blow recently after government agencies pulled up over 50 popular medicine brands. How do patients trust their medicines?
Nandini Piramal, chairperson, Piramal Pharma; image courtesy of Piramal Pharma. Synopsis Piramal Pharma’s management is optimistic that with revenue growth and margin expansion, it will be able to trim debt over the next five years. But the capital-intensive nature of its main contract manufacturing business scaling remains a challenge. Will Piramal Pharma be able to […]
Technicians fly a drone to deliver medical supplies during testing at Gauribidanur, near Banglore. Synopsis The use of drones in healthcare is in its test phase. There are already instances of medical drones transporting live organs for transplant, delivering vaccines in remote areas, or carrying oxygen cylinders. However, for medical drones to become mainstream, technical, […]
Collage by Manali Ghosh Synopsis 23andMe, a pioneer in genetic testing, struggles to maintain its early success. As quickly as it soared, its market value plummeted, leaving the company’s future uncertain. ET Prime examines the challenges faced by 23andMe, along with opportunities and potential implications for India’s genetic-testing market. Unravelling precise family history and ancestry […]